Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FPF300 plus dexamethasone induction therapy for POEMS (Crow-Fukase) syndrome
jRCT2091220135Completed
- Sponsor
- Chiba University Hospital
- Start
- Aug 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of thalidomide in osteosclerotic myeloma (POEMS), sponsored by Chiba University Hospital. Primary endpoints: Adverse events during FPF300 administration and Peripheral blood stem cell harvest feasibility. Started Aug 2013; status: completed.
02
Drugs
thalidomide
03
Conditions
osteosclerotic myeloma (POEMS)
Beyond the preview
Go deeper on jRCT2091220135.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2091220135.